This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer

NCT00034918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Metastases, Neoplasm

Interventions

DRUG: ZD6474

Sponsor

Genzyme, a Sanofi Company